There is a good reason why the U.S. is backward in in the development of phage therapy.
"That's there. Here, in the U.S., the regulatory system is designed to handle one-size-fits-all drugs, not quickly changing individual meds. The FDA would require every phage to go through a multi-year testing process – by which time the bug may have evolved again."
Once again government is the problem.
ruveyn
